Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Redesign Health

Health Tech & Medtech · New York City, United States · Founded 2018 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Venture studio that partners with entrepreneurs to identify, launch, and scale new businesses

Investors

10 investors on Redesign Health's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage
UPMC Enterprises
TriplePoint Capital
Declaration Partners
Samsung Next
True North Advisors
CVS Health
Eden Global Partners
Euclidean Capital
Blisce
General Catalyst

Global footprint

Where Redesign Health has talent and traffic

AI talent share
0.4% of workforce is AI talent
(1 of 260 staff)
Core AI00%
Other AI10.38%
Non-AI workforce25999.62%
Workforce by country
10 countries with
team presence
🇺🇸 United States91.7%
🇮🇳 India3.3%
🇨🇦 Canada1.4%
🇸🇦 Saudi Arabia0.9%
🇬🇧 United Kingdom0.8%
Top 5 of 10 shown
Web traffic by country
30K monthly visits
across markets
🇺🇸 United States64.7%
🇮🇳 India29.3%
🇬🇧 United Kingdom2%
🇩🇪 Germany1%
🇨🇦 Canada1%
Top 5 markets shown

Capital deployed

Redesign Health's 40 investments and acquisitions.

Every disclosed deal where Redesign Health appeared as a backer or acquirer, 2018–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

40 deals across Redesign Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Redesign Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        40 of 40 deals

        Sentiment on X

        What X is saying about Redesign Health

        An AI-synthesized read of the highest-engagement posts about Redesign Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Redesign Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.